Nuformix plc (LON:NFX – Get Free Report)’s share price was up 18.8% during trading on Friday . The stock traded as high as GBX 0.06 ($0.00) and last traded at GBX 0.06 ($0.00). Approximately 47,841,488 shares traded hands during trading, an increase of 195% from the average daily volume of 16,233,574 shares. The stock had previously closed at GBX 0.05 ($0.00).
Nuformix Price Performance
The company has a debt-to-equity ratio of 1.17, a current ratio of 1.12 and a quick ratio of 3.35. The company has a 50 day moving average price of GBX 0.05 and a 200 day moving average price of GBX 0.11. The firm has a market cap of £532,551.50, a PE ratio of -1.63 and a beta of 1.22.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Featured Articles
- Five stocks we like better than Nuformix
- There Are Different Types of Stock To Invest In
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- What Does Downgrade Mean in Investing?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
